Wolters Kluwer (0NMU)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 87.15 |
|---|---|
| 52-week range | 54.67 – 114.20 |
| Return, 1 month / 3 months | +27.0% / +33.1% |
| Return, 1 year / 3 years | −20.1% / −20.9% |
| Trend | Uptrend |
| RSI (14) | 76 |
| Volatility (1 year) | 39.4% |
| Worst drawdown (1 year) | -48.6% |
| Average daily value traded | 19.48M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wolters Kluwer is a provider of professional information, software and services, based in the Netherlands. It serves lawyers, tax and accounting specialists, healthcare professionals, and risk and compliance teams. Its offerings include legal and regulatory research tools, clinical decision support resources for hospitals and clinicians, and software for tax, audit and finance work. Customers use these products to find reliable guidance, manage compliance and complete complex professional tasks.
On this site Wolters Kluwer appears as a stock on the London Stock Exchange (UK), code 0NMU, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wolters Kluwer (0NMU) trades on the London Stock Exchange in UK. It last closed at EUR 87.15 on 27 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,479 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.1% and over the last three months it rose 33.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.9% | ||
| From 52-week high | -23.3% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 33.1% | ||
| 6-month return | 36.7% | ||
| 12-month return, skipping the last month | -37.1% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.6% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 19.48M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +27.0% |
| 3 months | +33.1% |
| 6 months | +36.7% |
| 1 year | −20.1% |
| 3 years | −20.9% |
| 5 years | +5.9% |
Signals
| 50-day / 200-day average | 72.15 / 66.09 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | EUR 1.0100 |
| 22 May 2026 | EUR 1.5900 |
| 26 Aug 2025 | EUR 0.9300 |
| 19 May 2025 | EUR 1.5000 |
| 27 Aug 2024 | EUR 0.8300 |
| 10 May 2024 | EUR 1.3600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.